Both visual acuity and refractive results improved in patients undergoing deep intrastromal arcuate keratotomy with in situ keratomileusis for treatment of high astigmatism after keratoplasty, according to a study.The two-step DIAKIK procedure was perf…
Author: Healio ophthalmology
Oxurion completes enrollment in plasma kallikrein inhibitor trial
Oxurion NV has completed enrollment in a phase 1 study of its plasma kallikrein inhibitor for treatment of diabetic macular edema, according to a press release.The safety of a single intravitreal injection of THR-149 will be evaluated in 15 patients wi…
Xbrane sets sales goals for ranibizumab biosimilar
Xbrane Biopharma has begun a phase 3 trial of its lead product Xlucane and announced a sales target for the biosimilar, according to a press release.Xlucane, a ranibizumab (Lucentis, Novartis/Genentech) biosimilar, is being co-developed and commerciali…
2CTech begins nanoparticle retina treatment trials
2CTech Inc. has initiated a clinical trial program for quantum dots, a nanoparticle technology treatment candidate for retinal diseases, according to a press release.The study will test the safety and efficacy of quantum dots – semiconductor crystallin…
VIDEO: Small relaxing incisions may allow easier DMEK surgery
Mark S. Hansen, MD, and David R. Hardten, MD, demonstrate a novel technique that facilitates performance of Descemet’s membrane endothelial keratoplasty.The technique incorporates two small relaxing incisions placed approximately 4 clock hours apart at…
Specialists offer their perspectives at Cornea360
The inaugural Cornea360 meeting took place in Scottsdale, Arizona, earlier this month, bringing together cornea specialists from across the country.Healio.com/OSN was on site at the meeting to interview key opinion leaders and presenters.Here are the t…
Research shows microglia may control neuroinflammation
Research from Massachusetts Eye and Ear has shown that microglia may serve as facilitators of neuroinflammation in autoimmune uveitis.Researchers described in a press release the role of microglia in directing the initiation of autoimmune uveitis by or…
FDA approves generic tobramycin from Alembic
The FDA has approved an abbreviated new drug application for Alembic Pharmaceuticals’ tobramycin ophthalmic solution USP 0.3%, according to a press release.The generic drug, which is equivalent to Tobrex ophthalmic solution 0.3% (Novartis), is indicate…
Ophthalmologists push for better access to care in annual Capitol Hill visit
In an effort to lobby for better access to care, discuss important issues with lawmakers and increase education, more than 400 ophthalmologists traveled to Washington recently for the American Academy of Ophthalmology’s annual Capitol Hill visit.Michae…
Rocklatan approval tops recent glaucoma news
The FDA’s approval of Rocklatan and news updates from the American Glaucoma Society meeting were among the most-read glaucoma-related articles on Healio.com/OSN in recent weeks.Here are the top five recent glaucoma stories: FDA approves Rocklatan for o…
Bausch + Lomb to initiate clinical trials for Technolas Teneo excimer laser
Bausch + Lomb will begin a clinical trial series of its Technolas Teneo excimer laser for vision correction surgery, the company announced in a press release.Designed to correct myopia and myopic astigmatism, the Technolas Teneo laser system is the sam…
FDA approves generic loteprednol etabonate from Akorn
The FDA has approved an abbreviated new drug application for Akorn’s loteprednol etabonate ophthalmic suspension 0.5%, according to a press release.“This is a really exciting approval for Akorn as we believe it is a first generic approval for lotepredn…
Depo-Medrol warning tops OSN’s news of the week
Here are some of the top stories on Healio.com/OSN in the past week: Remove Depo-Medrol from ophthalmological surgical suites to avoid accidental retinal toxicityMethylprednisolone acetate, which has similar packaging and appearance to triamcinolone ac…
OSN’s Publication Exclusives focus on preparing for future of ophthalmology
The April 25 issue of Ocular Surgery News focuses on practice management and prepping for how ophthalmic care will work in the future.Read some of the issue online here: Cover StoryChange is inevitable: Prepare for a challenging future in ophthalmology…
VIDEO: Keynote lecture on megatrends in ophthalmology
ORLANDO — At Cataract Surgery: Telling It Like It Is, Richard L. Lindstrom, MD, delivers his keynote lecture on megatrends in ophthalmology titled “Do you see what I see?”
First patient dosed in Innovent wet AMD trial
Innovent Biologics has dosed the first patient in a phase 1 trial of IBI302, the company’s wet age-related macular degeneration treatment candidate, according to a press release.A single intravitreal injection of IBI302, a recombinant fully human bispe…
Visual acuity gains reported in phase 3 trial of Leber hereditary optic neuropathy treatment
GenSight Biologics’ gene therapy treatment candidate for Leber hereditary optic neuropathy showed continuous recovery of visual function in a phase 3 trial, according to a press release.Best corrected visual acuity improved by an equivalent of 21 ETDRS…
Partners named for children’s vision and eye health program
The Better Vision Together – Community of Practice program from the National Center for Children’s Vision and Eye Health at Prevent Blindness has its first partners, the organization announced in a press release.The 3-year project aims to improve visio…
3 ways to reduce burnout
PHILADELPHIA — Data indicate that rates of physician burnout are declining, but it remains a significant issue for clinicians, a speaker at the American College of Physicians Internal Medicine Meeting told attendees.A study recently published in Mayo C…
Oertli launches upgraded Faros surgical platform
Oertli Instrumente has launched an upgrade to its Faros compact surgical platform for cataract, vitrectomy and glaucoma surgery.The upgrade includes a new design to make surgery easier to perform, with instrument connections accessible from the front. …